Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Neoplasms × Induction Chemotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 11 Leukemia, Myeloid, Acute 4 Nasopharyngeal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Myelodysplastic Syndromes 2 Lung Neoplasms 2 Turcot syndrome 1 Tongue Neoplasms 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Patient Outcome Assessment 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Medulloblastoma 1 Lymphoma 1 Locally Advanced Malignant Neoplasm 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Gemcitabine 616 130-nm albumin-bound paclitaxel 174 Fluorouracil 170 Oxaliplatin 155 Albumin-Bound Paclitaxel 138 Leucovorin 121 Capecitabine 120 Irinotecan 104 Radiotherapy 89 Taxes 77 pembrolizumab 73 Cisplatin 70 Erlotinib Hydrochloride 65 Radiosurgery 61 Bevacizumab 50 Nivolumab 49 Cyclophosphamide 46 Magnetic Resonance Spectroscopy 45 Drug Therapy 44 folfirinox 39 Specimen Handling 37 Docetaxel 37 Cetuximab 36 irinotecan sucrosofate 35 S 1 (combination) 34 Biopsy 33 Blood Specimen Collection 31 Pancreaticoduodenectomy 29 Paclitaxel 29 Radiation 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01827553 2024-04-11

CONKO-007

University of Erlangen-Nürnberg Medical School

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡